Amit Sachdev, EVP, Chief Patient Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 45 shares at $215.59 ($10K) on 2021-05-17, disclosed to the SEC on 2021-05-19.
Scheduled sale ($10k) by EVP, Chief Patient Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $215.59 | 8 | $2K | 17.7% |
| 2 | $216.40 | 32 | $7K | 71.1% |
| 3 | $217.27 | 5 | $1K | 11.2% |
| Total | $216.35 avg | 45 | $10K | 100% |
| Filing → |
| VRTX | SELL | 2024-05-17 | $14K | — | Filing → |
| VRTX | SELL | 2024-02-27 | $2.6M | — | Filing → |
| VRTX | SELL | 2024-02-23 | $2.7M | — | Filing → |